Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution
As a platform for hepsin-specific drug delivery, we previously prepared IPLVVPLRRRRRRRRC peptide (RIPL)-conjugated nanostructured lipid carriers (RIPL-NLCs) composed of Labrafil<sup>®</sup> M 1944 CS (liquid oil) and Precirol<sup>®</sup> ATO 5 (solid lipid)....
Main Authors: | Chang Hyun Kim, Si Woo Sung, Eun Seok Lee, Tae Hoon Kang, Ho Yub Yoon, Yoon Tae Goo, Ha Ra Cho, Dong Yoon Kim, Myung Joo Kang, Yong Seok Choi, Sangkil Lee, Young Wook Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/10/4/199 |
Similar Items
-
RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells
by: Lee SG, et al.
Published: (2018-06-01) -
pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation
by: Kim CH, et al.
Published: (2018-10-01) -
Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats
by: Zakarial Ansar FH, et al.
Published: (2020-10-01) -
Re-examination of Steric Substituent Constants by Molecular Mechanics
by: Shin-ichi Kuroda, et al.
Published: (2005-01-01) -
A method to improve quantitative radiotracing‐based analysis of the in vivo biodistribution of drug carriers
by: Nikša Roki, et al.
Published: (2021-05-01)